Measurement of Patient-Derived Glioblastoma Cell Response to Temozolomide Using Fluorescence Lifetime Imaging of NAD(P)H

Personalized strategies in glioblastoma treatment are highly necessary. One of the possible approaches is drug screening using patient-derived tumor cells. However, this requires reliable methods for assessment of the response of tumor cells to treatment. Fluorescence lifetime imaging microscopy (FL...

Descripción completa

Detalles Bibliográficos
Autores principales: Yuzhakova, Diana V., Sachkova, Daria A., Shirmanova, Marina V., Mozherov, Artem M., Izosimova, Anna V., Zolotova, Anna S., Yashin, Konstantin S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301219/
https://www.ncbi.nlm.nih.gov/pubmed/37375743
http://dx.doi.org/10.3390/ph16060796

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10301219/
https://www.ncbi.nlm.nih.gov/pubmed/37375743
http://dx.doi.org/10.3390/ph16060796

Ejemplares similares